腹膜透析患者接種SARS-CoV-2疫苗現況分析－北區醫學中心經驗

Current Status of SARS-CoV-2 Vaccination in Patients with Peritoneal Dialysis-One Hospital Experience

廖秋萍(Chiu-Ping Liao) ； 闕淑能(Shu-Neng Chueh) ； 劉蕙婷(Hui-Ting Liu) ； 陳怡婷(Yi-Ting Chen) ； 楊紹佑(Shao-Yu Yang) ； 姜至剛(Chih-Kang Chiang) ； 林水龍(Shuei-Liong Lin) ； 洪冠予(Kuan-Yu Hung) ； 陳永銘(Yung-Ming Chen)

《腎臟與透析》 34卷4期 (2022/12) Pp. 199-204

https://doi.org/10.6340/KD.202212_34(4).0009

摘要

本單位2021年6～11月453位腹膜透析患者，接種「新冠疫苗」第一、二劑的副作用由護理師以問卷方式進行面談或電話訪查。至11月底完成兩劑疫苗接種者共356人（占78.6%），僅完成一劑接種者37人（占8.2%），未注射人數60人（占13.2%）。ChAdOx1 nCoV-19（Oxford-AstraZeneca, AZ）及mRNA-1273（Moderna ［莫德納］）疫苗接種第一劑後皆以注射部位紅／腫／痛比例最高。AZ第二劑注射後大多無不適症狀，莫德納第二劑仍以注射處紅／腫／痛最多，且較第一劑反應更大，但接種反應皆不影響透析患者換液及生命徵象。

關鍵字

腹膜透析 ； 新型冠狀病毒感染症 ； 疫苗

並列摘要

Total 453 patients with peritoneal dialysis were enrolled from June to November 2021. These patients were surveyed with questionnaire. Three hundred and fifty-six of whom (78.6%) had received two doses of COVID-19 vaccine, 37 patients (8.2%) only received one dose of COVID-19 vaccine, and 60 patients (13.2%) did not. Most of side effects after vaccination were local reactions, such as redness, swelling, and pain. As previous studies, the side effects of ChAdOx1 nCoV-19 (Oxford-AstraZeneca, AZ) vaccine were more severe in the first dose. However, the reaction of mRNA-1273 (Moderna) vaccine the second dose more severe than the first dose.

並列關鍵字

peritoneal dialysis ； coronavirus disease (COVID) ； vaccine